SHENZHEN WANHE PHARMACEUTICAL CO., LTD.

Year of Establishment: 1992

Total Assets(USD): choose not to disclose

Total Number of Staff: less than 10 person

Main Competitive Advantages: Brandname,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages: Core competitiveness 1. The enterprise undertakes creation of the national major new drug and developes a first class new drugs DHMEQ 2.Orally disintegrating technology is in the lead in China and in the world 3.Multi-layer dropping pill technology is initiative in China, and is in the lead in the world 4.Top-ranking professional marketing team focus on digestive, hepatic and renal diseases 5.Rich resources of medicine and medical specialists is built upon over thirty year’s close cooperation and sincerity 6.Profound international partners are established upon over sixty year’s mutual trust and beneficial cooperation 7.The enterprise established the Shenzhen Enterprise Technology Center, and carry out industrial-academic-researches join with domestic and foreign universities and scientific institutions

Patents and Copyrights: 31 authorized patents